Migraine News

If you happened to miss Part 1 of 2 in this series, click here to see what you've missed so far: [Again, as previously noted, I'll do my best to...

If you take over-the-counter Excedrin®, you should check your bottle to see if it was affected by a recent manufacturing defect. Several Excedrin products were recalled in late December 2020...

Our world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people...

On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given...

The United States Food and Drug Administration (US FDA) has just approved Vyepti™ for the preventive treatment of migraine. Vyepti (eptinezumab-jjmr) will be the first intravenous (IV) preventive treatment on...

One June 4, 2019 the FDA approved Emgality (galcanezumab-gnlm) for the treatment of episodic cluster headache in adults. Emgality is a CGRP (calcitonin-gene related peptide) antagonist brought to market by...

You might notice a few changes in the way things look when you visit Migraine.com. Never fear! You still have the same tools for finding info and connecting with others...

Have you been prescribed Ajovy and/or taken your first dose? If so, we'd like to hear from you. Please enter your email information below and we will contact you for...

Managing symptoms of migraine is difficult enough, but emotional and mental challenges can also arise. Often, people aren’t just coping with one chronic condition, but several, and it can have...

Have a question about migraines and aren’t sure where to turn? The Q&A feature helps you get quick answers and suggestions from other community members. You can search through previously...

You may have noticed some changes around Migraine.com. We’re thrilled to announce that we’ve added some new features and functionality to provide an even better experience for the most important...

Want to get more involved in the Migraine & Cluster communities? Here's a list of in-person events for the rest of 20I7. There are events to help raise funds (walk/races...

In addition to pain, sickness, and - for many - daily disability, migraine carries a severe burden of discrimination and negativity from many community members. This is social stigma. History...

The migraine world has been abuzz lately about new drugs in development to prevent migraine attacks. These drugs, called monoclonal antibodies, target an amino acid called CGRP (calcitonin gene-related peptide)...

Spring TMS is non-drug treatment that uses a technology called transcranial magnetic stimulation to abort migraine attacks. Research has documented few possible side effects from using the device. FDA approved...

I am writing to invite you to participate in an important survey designed to better understand the dietary factors that influence migraines. Given the amount of people are impacted by...

Migraine Awareness Month is right around the corner! Awareness month is all about sharing how devastating life with migraine - an often invisible illness - can be. How has migraine...

The American Academy of Neurology released information about a new study this week that addresses the risk of heart attack and stroke for women living with migraine with aura. While...

Migraine.com just celebrated its 2-year anniversary as a community resource for people with migraine. About six months after the site was first launched, we asked you what you thought about...

I just returned from this year’s European Federation of Neurological Sciences meeting where thousands of neurologists from all over the world gather to discuss their latest research. It’s an exciting...